paroxetine has been researched along with Psychomotor Agitation in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emilsson, JF; Eriksson, E; Hieronymus, F; Lisinski, A; Näslund, J; Nilsson, S | 1 |
| Ahl, B; Anghelescu, IG; Wilhelm, R | 1 |
| Coffey, DB; John, N; Potter, PO | 1 |
| Heinz, A; Ströhle, A; Trendelenburg, G | 1 |
| Dursun, SM; Haddad, PM | 1 |
| Arita, S; Morishita, S | 1 |
| Cameron, AJ; Liang, R; Ng, BK; Rahman, H | 1 |
| Danhof, M; Della Pasqua, O; Gomeni, R; Santen, G | 1 |
| Draper, B; Meares, S | 1 |
| Bassanelli, AG; Naughton, BJ; Ramadan, FH | 1 |
| Dunbar, GC; Fuell, DL | 1 |
2 review(s) available for paroxetine and Psychomotor Agitation
| Article | Year |
|---|---|
Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
Topics: Adult; Akathisia, Drug-Induced; Anxiety; Citalopram; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
[Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review].
Topics: Anesthesia, General; Drug Interactions; Dystonia; Enzyme Inhibitors; Eye Movements; Female; Humans; Infusions, Intravenous; Methylene Blue; Middle Aged; Obsessive-Compulsive Disorder; Parathyroidectomy; Paroxetine; Postoperative Complications; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tachycardia | 2008 |
2 trial(s) available for paroxetine and Psychomotor Agitation
| Article | Year |
|---|---|
Treatment of verbal agitation with a selective serotonin reuptake inhibitor.
Topics: Aged; Aged, 80 and over; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Verbal Behavior | 2000 |
The anti-anxiety and anti-agitation effects of paroxetine in depressed patients.
Topics: Anxiety; Databases, Factual; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Psychomotor Agitation | 1992 |
7 other study(ies) available for paroxetine and Psychomotor Agitation
| Article | Year |
|---|---|
Dextrometorphan-Paroxetine, But Not Dronabinol, Effective for Treatment-Resistant Aggression and Agitation in an Elderly Patient With Lewy Body Dementia.
Topics: Aged; Aggression; Cannabinoid Receptor Agonists; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dronabinol; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Lewy Body Disease; Male; Paroxetine; Psychomotor Agitation | 2017 |
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment | 2012 |
Gamma-hydroxybutyrate dependence with social phobia.
Topics: Adjuvants, Anesthesia; Adult; Cognitive Behavioral Therapy; Humans; Male; Paroxetine; Phobic Disorders; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Sodium Oxybate | 2004 |
Re: Depression, stroke diagnosis, and SSRI discontinuation syndrome.
Topics: Aged; Anxiety; Ataxia; Dementia, Multi-Infarct; Humans; Magnetic Resonance Imaging; Male; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2004 |
Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression.
Topics: Cohort Studies; Cyclopropanes; Depression; Drug Administration Schedule; Fluvoxamine; Humans; Milnacipran; Paroxetine; Psychomotor Agitation; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires | 2004 |
Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy.
Topics: Depressive Disorder, Major; Double-Blind Method; Endpoint Determination; False Negative Reactions; Humans; Linear Models; Longitudinal Studies; Paroxetine; Placebos; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Agitation; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sleep Initiation and Maintenance Disorders; Suicide; Time Factors; Treatment Outcome | 2008 |
Treatment of vocally disruptive behaviour of multifactorial aetiology.
Topics: Aged; Akathisia, Drug-Induced; Behavior Therapy; Dementia; Depression; Female; Homes for the Aged; Humans; Mental Disorders; Noise; Nursing Homes; Paroxetine; Patient Compliance; Physical Therapy Modalities; Psychomotor Agitation; Restraint, Physical; Risperidone; Verbal Behavior | 1999 |